Tue, September 26, 2023

Ed Arce Maintained (VERA) at Strong Buy with Increased Target to $25 on, Sep 26th, 2023

Ed Arce of HC Wainwright & Co., Maintained "Vera Therapeutics, Inc." (VERA) at Strong Buy with Increased Target from $10 to $25 on, Sep 26th, 2023.

Ed has made no other calls on VERA in the last 4 months.



There are 2 other peers that have a rating on VERA. Out of the 2 peers that are also analyzing VERA, 1 agrees with Ed's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Laura Chico of "Wedbush" Maintained at Hold with Increased Target to $16 on, Friday, August 11th, 2023


This is the rating of the analyst that currently disagrees with Ed


  • Vamil Divan of "Guggenheim" Initiated at Strong Buy and Held Target at $27 on, Wednesday, August 16th, 2023